Compound Detail
CHEMBL3907479
FGFR INHIBITOR DEBIO 1347 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL3907479 |
| Name | FGFR INHIBITOR DEBIO 1347 |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | BEMNJULZEQTDJY-UHFFFAOYSA-N |
13
Targets
26
Activities
2
Assay Types
4
PK Parameters
20
Publications
1
Known Names
2
Indications
3
Mechanisms
Molecular Properties
356.4
MW (Da)
3.35
ALogP
5
HBA
3
HBD
105.4
PSA (Ų)
0.43
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Fibroblast growth factor receptor 2 inhibitor | INHIBITOR | Fibroblast growth factor receptor 2 | ✓ | ✓ |
| Fibroblast growth factor receptor 3 inhibitor | INHIBITOR | Fibroblast growth factor receptor 3 | ✓ | ✓ |
| Fibroblast growth factor receptor 1 inhibitor | INHIBITOR | Fibroblast growth factor receptor 1 | ✓ | ✓ |
Indications
Neoplasms Breast Neoplasms
Activity Summary
IC50 21 meas. best 8.3
Kd 5 meas. best 8.52
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Fibroblast growth factor receptor 1 CHEMBL3650 | Kd | 8.52 | 8.52 | 3.0 | 1 |
| Fibroblast growth factor receptor 1 CHEMBL3650 | IC50 | 8.3 | 8.0975 | 5.0 | 4 |
| Ephrin type-B receptor 6 CHEMBL5836 | Kd | 8.15 | 8.15 | 7.0 | 1 |
| Fibroblast growth factor receptor 2 CHEMBL4142 | IC50 | 8.12 | 8.0 | 7.6 | 4 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 7.77 | 6.5 | 17.0 | 2 |
| MAP kinase-activated protein kinase 2 CHEMBL2208 | Kd | 7.75 | 7.75 | 18.0 | 1 |
| Fibroblast growth factor receptor 3 CHEMBL2742 | IC50 | 7.75 | 7.6825 | 18.0 | 4 |
| Histone deacetylase 6 CHEMBL1865 | IC50 | 7.08 | 7.08 | 83.8 | 1 |
| Fibroblast growth factor receptor 4 CHEMBL3973 | IC50 | 6.54 | 6.54 | 290.0 | 2 |
| Proto-oncogene tyrosine-protein kinase receptor Ret CHEMBL2041 | Kd | 6.11 | 6.11 | 783.0 | 1 |
| Pyridoxal kinase CHEMBL1075181 | Kd | 5.68 | 5.68 | 2110.0 | 1 |
| Vascular endothelial growth factor receptor 2 CHEMBL279 | IC50 | 5.68 | 5.68 | 2100.0 | 2 |
| Proto-oncogene tyrosine-protein kinase Src CHEMBL267 | IC50 | 5.23 | 5.23 | 5900.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 5.16 | 5.16 | 6900.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 102000.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 26000.0 | ng.hr.mL-1 | Homo sapiens |
| CL | 13.0 | mL.min-1.g-1 | Homo sapiens |
| F | 30.0 | % | Macaca fascicularis |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine